Treatment of acromegaly with the nonpeptide, highly selective somatostatin receptor type 2 agonist paltusotine
Article in Best Practice & Research Clinical Endocrinology & Metabolism (May 2024)
The most recent citing publications are shown below. View all 25 publications that cite this research output on Dimensions.
Article in Best Practice & Research Clinical Endocrinology & Metabolism (May 2024)
Article in Best Practice & Research Clinical Endocrinology & Metabolism (February 2024)
Article in Current Medical Research and Opinion (February 2024)